Early Detection Research Network

Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.

No abstract available.

Barón A, Bemis L, Bunn PA, Chan DC, Coldren C, Franklin WA, Gazdar A, Gustafson D, Helfrich BA, Hirsch FR, Minna J, Raben D, Varella-Garcia M, Zeng C


Clin. Cancer Res., 2006, 12 (23)